Clinical Trial Update: Role of Circulating Pyrophosphate as a Biomarker of Mediacalcinosis in Type 2 Diabetic Patients [NA]

View source ↗

Summary

A clinical trial is evaluating whether circulating pyrophosphate can serve as a biomarker for mediacalcinosis in patients with Type 2 diabetes mellitus; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Type 2 Diabetes, Type 2 Diabetes Patients | NA | Status: RECRUITING